Viewing Study NCT05036135

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2026-05-19 @ 9:09 AM
Study NCT ID: NCT05036135
Status: TERMINATED
Last Update Posted: 2024-08-23
First Post: 2021-08-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)
Sponsor: Aerovate Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Arterial Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pulmonary Arterial Hypertension View
None Lungs View
None Pulmonary View
None PAH View
None AV-101 View
None imatinib View
None IMPAHCT View